English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Industrial Chemical General
旭陽集團(1907.HK)致力打造己內酰胺龍頭
May 18, 2021 07:00 HKT
SDK full-scale development of ST60-HSM Aluminum Alloy Board with high conductivity and high strength for On-board Bus Bar
Apr 27, 2021 12:30 HKT
Azelis meluncurkan 'Aksi 2025', sebagai penegasan atas keberlanjutan sebagai salah satu penggerak utama dalam strategi pertumbuhan
Apr 13, 2021 10:00 HKT
아젤리스, 성장 전략의 핵심 동력인 지속가능성 확보 위한 ‘Action 2025’ 발표
Apr 12, 2021 15:00 HKT
阿澤雷斯發布“2025行動”,確認可持續發展是公司增長戰略的關鍵驅動因素
Apr 06, 2021 09:00 HKT
阿泽雷斯发布“2025行动”,确认可持续发展是公司增长战略的关键驱动因素
Apr 06, 2021 09:00 HKT
ZC Rubber Focuses on Innovation and Growth at Global Online Dealer Conference
Mar 31, 2021 13:00 HKT
Azelis releases 'Action 2025', confirming sustainability as a key driver in growth strategy
Mar 31, 2021 11:00 HKT
Showa Denko Announces Notice of Execution of Basic Agreement regarding Tender Offer over Subsidiary
Mar 04, 2021 17:00 HKT
Maculus Therapeutix欢迎Privity,为新型药物输送平台筹集资金
Feb 24, 2021 07:00 HKT
Maculus Therapeutix歡迎Privity,為新型藥物輸送平台籌集資金
Feb 24, 2021 07:00 HKT
Maculus Therapeutix welcomes Privity, Prepares Capital Raise for Novel Drug Delivery Platform
Feb 19, 2021 07:00 HKT
Showa Denko Revises Forecast of Consolidated Performance, and to Record Impairment Losses (Extraordinary Losses)
Feb 12, 2021 10:00 HKT
Elastomers develop stronger bonds of attachment
Feb 12, 2021 01:00 HKT
Showa Denko Invests in AMI Automation
Feb 08, 2021 11:00 HKT
럭스 리서치, 2021년에 주목할 만한 기술 순위를 발표
Feb 04, 2021 08:00 HKT
Materials coloured like a peacock
Jan 26, 2021 01:00 HKT
The Executive Talk: PTT Global Chemical PCL (SET:PTTGC)
Jan 20, 2021 13:00 HKT
Azelis Acquires Majority Shareholding in MKVN Chemicals and Viet Chemi
Jan 06, 2021 15:20 HKT
Azelis significantly increases its market presence in Vietnam through the acquisition of a majority shareholding in MKVN Chemicals and Viet Chemi
Jan 05, 2021 14:35 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: